FDAFDA · Food and drugs·Recall number D-1400-2012
Loxapine Capsules USP, 10mg, 100 count bottle, Rx only, Manufactured By: Watson Laboratories Inc., Corona, CA 92880 Rx only. NDC # 0591-0370-01
Published July 11, 2012 · Recall initiated: April 17, 2012
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used when packaged.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- LOXAPINE
- Manufacturer
- Watson Laboratories Inc
- Distributor
- Nationwide.
- UPC
- 0305910369019
- Lot
- Lot #s: 107886A, 107887A, 112874A, 144274A, 196483A, 201146A, 217265A, 260747B, 283308A, 313279A, 313279B, 327892A, 327893A, 327894A, 387239A, 387240A, 427259A, 427260A, 456251A.
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.